Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-02

Clinical Trial Update: Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS - Extension Trial [Phase 3]

View source ↗

Summary

An extension Phase 3 clinical trial update for glepaglutide evaluating long-term safety and efficacy in short bowel syndrome. The study is active but not recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glepaglutide (glepaglutide)

Snippet

Sponsor: Zealand Pharma | Conditions: Short Bowel Syndrome | Phase 3 | Status: ACTIVE_NOT_RECRUITING